HEADER OXIDOREDUCTASE 21-JUL-17 5OJC TITLE STRUCTURE OF MBQ2.1 NMH COMPND MOL_ID: 1; COMPND 2 MOLECULE: MYOGLOBIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PHYSETER CATODON; SOURCE 3 ORGANISM_COMMON: SPERM WHALE; SOURCE 4 ORGANISM_TAXID: 9755; SOURCE 5 GENE: MB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS MYOGLOBIN, NMH, N-METHYLHISTIDINE, HEME, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR T.HAYASHI,M.POTT,T.MORI,P.MITTL,A.GREEN,D.HIVERT REVDAT 3 17-JAN-24 5OJC 1 REMARK REVDAT 2 07-FEB-18 5OJC 1 JRNL REVDAT 1 24-JAN-18 5OJC 0 JRNL AUTH M.POTT,T.HAYASHI,T.MORI,P.R.E.MITTL,A.P.GREEN,D.HILVERT JRNL TITL A NONCANONICAL PROXIMAL HEME LIGAND AFFORDS AN EFFICIENT JRNL TITL 2 PEROXIDASE IN A GLOBIN FOLD. JRNL REF J. AM. CHEM. SOC. V. 140 1535 2018 JRNL REFN ESSN 1520-5126 JRNL PMID 29309143 JRNL DOI 10.1021/JACS.7B12621 REMARK 2 REMARK 2 RESOLUTION. 1.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.11.1_2575: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 3 NUMBER OF REFLECTIONS : 36171 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.193 REMARK 3 FREE R VALUE : 0.215 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.530 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.2100 - 3.0123 0.96 2544 149 0.1773 0.2026 REMARK 3 2 3.0123 - 2.3911 0.97 2533 148 0.2013 0.2078 REMARK 3 3 2.3911 - 2.0889 0.97 2499 147 0.1830 0.1946 REMARK 3 4 2.0889 - 1.8979 0.92 2397 139 0.1877 0.2040 REMARK 3 5 1.8979 - 1.7618 0.95 2442 143 0.1941 0.2199 REMARK 3 6 1.7618 - 1.6580 0.95 2422 142 0.1955 0.2453 REMARK 3 7 1.6580 - 1.5749 0.95 2452 143 0.1903 0.2202 REMARK 3 8 1.5749 - 1.5064 0.95 2443 143 0.1875 0.2326 REMARK 3 9 1.5064 - 1.4484 0.95 2423 142 0.1949 0.2035 REMARK 3 10 1.4484 - 1.3984 0.92 2377 140 0.2165 0.2515 REMARK 3 11 1.3984 - 1.3547 0.94 2426 142 0.2297 0.2865 REMARK 3 12 1.3547 - 1.3159 0.94 2396 140 0.2339 0.2902 REMARK 3 13 1.3159 - 1.2813 0.94 2392 140 0.2592 0.2952 REMARK 3 14 1.2813 - 1.2500 0.94 2425 142 0.3042 0.3141 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.150 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.090 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 1296 REMARK 3 ANGLE : 0.925 1756 REMARK 3 CHIRALITY : 0.062 182 REMARK 3 PLANARITY : 0.005 218 REMARK 3 DIHEDRAL : 23.606 462 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5OJC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 21-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1200005495. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36215 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.250 REMARK 200 RESOLUTION RANGE LOW (A) : 39.191 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 93.7 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.48600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5OJ9 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SPG (PH 7.0), 30% PEG1500, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 25.90000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1280 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 7640 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 154 REMARK 465 SER A 155 REMARK 465 GLY A 156 REMARK 465 HIS A 157 REMARK 465 HIS A 158 REMARK 465 HIS A 159 REMARK 465 HIS A 160 REMARK 465 HIS A 161 REMARK 465 HIS A 162 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 20 76.03 -156.81 REMARK 500 LYS A 50 -50.60 -127.49 REMARK 500 ALA A 95 -130.33 -82.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 201 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MHS A 93 NE2 REMARK 620 2 HEM A 201 NA 90.0 REMARK 620 3 HEM A 201 NB 86.4 91.8 REMARK 620 4 HEM A 201 NC 91.2 178.7 88.0 REMARK 620 5 HEM A 201 ND 93.0 89.8 178.3 90.4 REMARK 620 6 IMD A 202 N1 176.0 86.0 93.7 92.7 87.0 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue HEM A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue IMD A 202 DBREF 5OJC A 0 153 UNP P02185 MYG_PHYCD 1 154 SEQADV 5OJC THR A 28 UNP P02185 ILE 29 CONFLICT SEQADV 5OJC ILE A 39 UNP P02185 THR 40 CONFLICT SEQADV 5OJC GLY A 45 UNP P02185 ARG 46 CONFLICT SEQADV 5OJC LEU A 46 UNP P02185 PHE 47 CONFLICT SEQADV 5OJC GLU A 63 UNP P02185 LYS 64 CONFLICT SEQADV 5OJC LEU A 68 UNP P02185 VAL 69 CONFLICT SEQADV 5OJC ALA A 95 UNP P02185 THR 96 CONFLICT SEQADV 5OJC HIS A 103 UNP P02185 TYR 104 CONFLICT SEQADV 5OJC PHE A 107 UNP P02185 ILE 108 CONFLICT SEQADV 5OJC THR A 140 UNP P02185 LYS 141 CONFLICT SEQADV 5OJC GLY A 154 UNP P02185 EXPRESSION TAG SEQADV 5OJC SER A 155 UNP P02185 EXPRESSION TAG SEQADV 5OJC GLY A 156 UNP P02185 EXPRESSION TAG SEQADV 5OJC HIS A 157 UNP P02185 EXPRESSION TAG SEQADV 5OJC HIS A 158 UNP P02185 EXPRESSION TAG SEQADV 5OJC HIS A 159 UNP P02185 EXPRESSION TAG SEQADV 5OJC HIS A 160 UNP P02185 EXPRESSION TAG SEQADV 5OJC HIS A 161 UNP P02185 EXPRESSION TAG SEQADV 5OJC HIS A 162 UNP P02185 EXPRESSION TAG SEQRES 1 A 163 MET VAL LEU SER GLU GLY GLU TRP GLN LEU VAL LEU HIS SEQRES 2 A 163 VAL TRP ALA LYS VAL GLU ALA ASP VAL ALA GLY HIS GLY SEQRES 3 A 163 GLN ASP THR LEU ILE ARG LEU PHE LYS SER HIS PRO GLU SEQRES 4 A 163 ILE LEU GLU LYS PHE ASP GLY LEU LYS HIS LEU LYS THR SEQRES 5 A 163 GLU ALA GLU MET LYS ALA SER GLU ASP LEU LYS GLU HIS SEQRES 6 A 163 GLY VAL THR LEU LEU THR ALA LEU GLY ALA ILE LEU LYS SEQRES 7 A 163 LYS LYS GLY HIS HIS GLU ALA GLU LEU LYS PRO LEU ALA SEQRES 8 A 163 GLN SER MHS ALA ALA LYS HIS LYS ILE PRO ILE LYS HIS SEQRES 9 A 163 LEU GLU PHE PHE SER GLU ALA ILE ILE HIS VAL LEU HIS SEQRES 10 A 163 SER ARG HIS PRO GLY ASP PHE GLY ALA ASP ALA GLN GLY SEQRES 11 A 163 ALA MET ASN LYS ALA LEU GLU LEU PHE ARG THR ASP ILE SEQRES 12 A 163 ALA ALA LYS TYR LYS GLU LEU GLY TYR GLN GLY GLY SER SEQRES 13 A 163 GLY HIS HIS HIS HIS HIS HIS MODRES 5OJC MHS A 93 HIS MODIFIED RESIDUE HET MHS A 93 11 HET HEM A 201 43 HET IMD A 202 5 HETNAM MHS N1-METHYLATED HISTIDINE HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM IMD IMIDAZOLE HETSYN HEM HEME FORMUL 1 MHS C7 H11 N3 O2 FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 IMD C3 H5 N2 1+ FORMUL 4 HOH *143(H2 O) HELIX 1 AA1 SER A 3 ALA A 19 1 17 HELIX 2 AA2 ASP A 20 HIS A 36 1 17 HELIX 3 AA3 HIS A 36 GLU A 41 1 6 HELIX 4 AA4 THR A 51 SER A 58 1 8 HELIX 5 AA5 SER A 58 LYS A 78 1 21 HELIX 6 AA6 HIS A 82 MHS A 93 1 12 HELIX 7 AA7 PRO A 100 HIS A 119 1 20 HELIX 8 AA8 PRO A 120 PHE A 123 5 4 HELIX 9 AA9 GLY A 124 LEU A 149 1 26 LINK C SER A 92 N MHS A 93 1555 1555 1.33 LINK C MHS A 93 N ALA A 94 1555 1555 1.33 LINK NE2 MHS A 93 FE HEM A 201 1555 1555 2.08 LINK FE HEM A 201 N1 IMD A 202 1555 1555 2.13 SITE 1 AC1 15 LYS A 42 PHE A 43 LEU A 68 LEU A 72 SITE 2 AC1 15 LEU A 89 SER A 92 MHS A 93 ILE A 99 SITE 3 AC1 15 HIS A 103 IMD A 202 HOH A 313 HOH A 315 SITE 4 AC1 15 HOH A 321 HOH A 329 HOH A 355 SITE 1 AC2 4 PHE A 43 HIS A 64 LEU A 68 HEM A 201 CRYST1 34.532 51.800 39.660 90.00 98.82 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.028959 0.000000 0.004495 0.00000 SCALE2 0.000000 0.019305 0.000000 0.00000 SCALE3 0.000000 0.000000 0.025516 0.00000